ArticleBMC gastroenterology2021

Development and validation of a novel competing risk model for predicting survival of esophagogastric junction adenocarcinoma: a SEER population-based study and external validation.

Tongbo Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.